Circulating adiponectin concentrations are reduced in obese individuals [10], and this reduction was proposed to have a crucial role in the pathogenesis of atherosclerosis and cardiovascular diseases associated with obesity and the metabolic syndrome [11,12]. Here, ADIPOQ is linked to cardiovascular disorder.